Excision BioTherapeutics Appoints Industry Veteran Lisa Danzig, M.D., as Chief Medical Officer
SAN FRANCISCO, July 29, 2021 (GLOBE NEWSWIRE) -- Excision BioTherapeutics Inc, the developer of CRISPR-based therapies intended to cure viral...
Month: July 2021
Sensus Healthcare to Host Second Quarter 2021 Financial Results and Business Update Conference Call on August 5, 2021
BOCA RATON, Fla, July 29, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in...
CytomX Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021
SOUTH SAN FRANCISCO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company...
Arbutus to Report Second Quarter 2021 Financial Results and Provide Corporate Update
WARMINSTER, Pa., July 29, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on...
Caladrius Biosciences to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021 at 4:30 p.m. Eastern Time
BASKING RIDGE, N.J., July 29, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage...
Brickell Biotech to Report Second Quarter 2021 Financial Results and Provide a Corporate Update on August 12, 2021
BOULDER, Colo., July 29, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on...
Treatment.com unveils a new medical library to create the future of AI healthcare
VANCOUVER, British Columbia, July 29, 2021 (GLOBE NEWSWIRE) -- Treatment.com International Inc. “Treatment or The Company” (CSE: TRUE), a healthcare...
Jounce Therapeutics to Announce Second Quarter 2021 Financial Results and Host a Conference Call on Thursday, August 5, 2021
CAMBRIDGE, Mass., July 29, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery...
Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial Results
SAN DIEGO, July 29, 2021 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the...
Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call
WATERTOWN, Mass., July 29, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development...
Kane Biotech Receives Decisions to Grant for Two European Patents Providing Broad Protection of coactiv+™ Technology for Wound Care, Skin Infections and Personal Care Formulations
WINNIPEG, Manitoba, July 29, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that it has received two Decisions to Grant...
Rhythm Pharmaceuticals Announces Senior Leadership Additions
Linda Shapiro Manning Headshot Linda Shapiro Manning, M.D., Ph.D., Senior Vice President, Clinical Pamela Carter Headshot Pamela Cramer, Chief Human...
Rubius Therapeutics Appoints Dannielle Appelhans as Chief Operating Officer
CAMBRIDGE Mass., July 29, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is genetically...
180 Life Sciences to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference
PALO ALTO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the...
SCYNEXIS Announces Two Oral Presentations on Pooled Data from the BREXAFEMME (Ibrexafungerp tablets) Phase 3 VANISH Program Demonstrating Consistent Efficacy in the Treatment for Vaginal Yeast Infections at the IDSOG 2021 Virtual Annual Meeting
The pooled data from two Phase 3 studies (VANISH-303 and VANISH-306) of one-day oral ibrexafungerp reflect a population that overwhelmingly...
IntelGenX to Report Second Quarter 2021 Financial Results on August 4, 2021 – Conference Call to Follow
SAINT LAURENT, Quebec, July 29, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it will...
InnerScope Hearing Technologies (OTC: INND) Upgraded to Pink Current by OTC Markets
InnerScope plans to upgrade to OTCQB as soon as practicableROSEVILLE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- ...
Cocrystal Pharma’s SARS-CoV-2 3CL Protease Lead CDI-45205 Demonstrates Broad-Spectrum Activity Against the SARS-CoV-2 Delta and Gamma Variants
BOTHELL, Wash., July 29, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that its SARS-CoV-2...
Impel NeuroPharma to Host Virtual Key Opinion Leader Event on August 6, 2021
SEATTLE, July 29, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (NASDAQ: IMPL), a late-stage biopharmaceutical company focused on the development...
Salarius Pharmaceuticals to Report Second Quarter 2021 Financial Results
Conference Call and Live Audio Webcast Scheduled for Thursday, August 5, 2021, 10:00 a.m. ETHOUSTON, July 29, 2021 (GLOBE NEWSWIRE)...